Endoscopic Strip Craniectomy for Treatment of Sagittal Craniosynostosis
NCT04721769 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2025-09-19
Summary
* Endoscopic strip craniectomy (ESC) with post-operative helmeting is the gold-standard treatment for isolated, non-syndromic sagittal craniosynostosis in children under 6 months of age as it is has been demonstrated to reduce perioperative morbidity when compared to more invasive procedures such as cranial vault remodeling. ESC is frequently performed with or without the use of lateral osteotomies with technical selection being largely based on surgeon preference.
* Previous studies have shown that there are no statistically significant differences in cranial expansion or complications between the two procedure variants; however, these studies are retrospective in nature and do not account for aesthetic outcomes.
* The purpose of this study is to compare the efficacy of ESC with or without the use of lateral osteotomies in regard to cranial expansion and aesthetic outcomes for children treated with isolated, non-syndromic sagittal craniosynostosis. In addition, we seek to investigate if there are any observable changes in perioperative morbidity between the two procedures.
Conditions
- Craniosynostosis, Sagittal
Interventions
- PROCEDURE
-
Endoscopic strip craniectomy (with lateral osteotomies) with post-operative helmet therapy
Endoscopic strip craniectomy is a surgical procedure performed to remove pathologic bone of the calvarium that includes the fused suture. Lateral osteotomies, also known as barrel-stave osteotomies, are performed by some surgeons because of their perceived benefit in regard to cranial expansion. Following surgery, orthotic helmet therapy is performed in order to mold the calvarium with the goals of optimizing contour.
- PROCEDURE
-
Endoscopic strip craniectomy (without lateral osteotomies) with post-operative helmet therapy
Endoscopic strip craniectomy is a surgical procedure performed to remove pathologic bone of the calvarium that includes the fused suture. Lateral osteotomies, also known as barrel-stave osteotomies, are performed by some surgeons because of their perceived benefit in regard to cranial expansion. Following surgery, orthotic helmet therapy is performed in order to mold the calvarium with the goals of optimizing contour.
Sponsors & Collaborators
-
Baylor College of Medicine
lead OTHER
Principal Investigators
-
David F Bauer, MD, MPH · Baylor College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Max Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-18
- Primary Completion
- 2025-05-01
- Completion
- 2025-05-01
Countries
- United States
Study Locations
More Related Trials
-
Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
NCT02881970 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Bilateral Recession or Unilateral Recession-Resection as Surgery for Infantile Esotropia
NCT00304577 ·Status: COMPLETED
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
NCT01904786 ·Status: WITHDRAWN ·Phase: PHASE1
-
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
NCT05581927 ·Status: WITHDRAWN ·Phase: NA
-
Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)
NCT07264166 ·Status: ENROLLING_BY_INVITATION
-
Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin
NCT01207778 ·Status: COMPLETED
-
Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
NCT00808704 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
ESWT as a Treatment for Chronic NHO in TBI Patients
NCT02331628 ·Status: COMPLETED ·Phase: NA
-
Becoming Children With Perinatal Anoxo-Ischemic Encephalopathy Without Indication of Therapeutic Hypothermia
NCT03744481 ·Status: COMPLETED
-
Amnioinfusion for Intrauterine Neuroprotection
NCT05513690 ·Status: UNKNOWN ·Phase: NA
-
Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
NCT03640494 ·Status: COMPLETED
-
Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy
NCT00890409 ·Status: COMPLETED ·Phase: PHASE3
-
Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
NCT02551003 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease
NCT02395783 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Metformin Treatment in Infants After Perinatal Brain Injury
NCT05590676 ·Status: TERMINATED ·Phase: PHASE1
-
Erythropoietin in Premature Infants to Prevent Encephalopathy
NCT02550054 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
NCT06429007 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Neonatal Hypoxic Ischemic Encephalopathy:Early Diagnosis and Management of Comorbidities
NCT03550612 ·Status: UNKNOWN
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
High-dose Erythropoietin for Asphyxia and Encephalopathy
NCT02811263 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
NCT01072045 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage
NCT03390530 ·Status: WITHDRAWN ·Phase: PHASE3